PSYCHOTHERAPY FOR ADOLESCENTS, CHildren AND ADULTS
In the second wave of psychedelic research, there are multiple trials taking place across the world.
This includes looking into their potential use to treat end-of-life anxiety and depression in the terminally ill (at the US’s John Hopkins University and NYU), for smoking cessation, alcoholism, anorexia, OCD, asthma, longevity and pain syndromes, as well as seven separate trials worldwide into the use of psilocybin to treat depression.
Read moreMurkiness and wishful thinking about an emerging scientific subject can be spun into certainty.
The vagus nerve is being hyped up by online influencers, making it seem easy to treat and fix a slew of health issues. What’s fact and fiction?
Read moreHere’s a wonderful article on how people with cluster headaches became unexpected psychedelic pioneers.
Read moreThat, in turn, can lead to serious or even fatal heart issues like arrhythmias or valvular heart disease.
So far, there’s been little research on the link between repeated psychedelics use and heart health, but this week, researchers at the University of Fribourg Center for Psychiatric Research in Switzerland published a paper in the Journal of Psychopharmacology reviewing the existing evidence.
“It is possible that chronic microdosing may carry a risk of fibrosis and valvular heart disease, which should be assessed in future studies,” the authors write.
“Any future work considering longer microdosing regimens should incorporate breaks and regular screening for vascular abnormalities.”
Here’s an interesting interview on what the club scene can tell us about drug use and public health.
Read moreA single dose of psilocybin has a lasting therapeutic effect on migraine headache, according to a new placebo-controlled study.
Read morePsychedelic drug users tend to have better overall physical health than non-users, this study finds.
Read more